Results 121 to 130 of about 361,585 (263)

P375: Implementing preemptive pharmacogenetic testing in populations to mitigate adverse cardiovascular events and identify high-risk individuals

Genetics in Medicine Open
Joy Sheng, Pooja Shende, Cristo Mochi, Joe Yearsley, Sherry Dadgar   +4 more
doaj   +1 more source

Personalized Medicine in Otolaryngology: Reflections on a Multidisciplinary Special Issue. [PDF]

J Pers Med
Abouzari M.
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

P308: The scope of incorporating preemptive pharmacogenomics testing for public healthcare

Genetics in Medicine Open
Joy Sheng, Serjio Rubio, Nirmal Shende, Sherry Dadgar   +3 more
doaj   +1 more source

Is ANCA-Associated Vasculitis Ready for Personalized Medicine? [PDF]

Kidney Int Rep
Popa CA, Walsh M.
europepmc   +1 more source

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Arthritis Care &Research, EarlyView.
Objective The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet, Camille Guertin, Maggie Larché, Isabelle Ferdinand, Marie Hudson, May Y. Choi, Mohammed Osman, Janet Pope, Carter Thorne, Murray Baron, Sasha Bernatsky, Sabrina Hoa   +11 more
wiley   +1 more source

New Personalized Medicine Model for Medication Management. [PDF]

J Pers Med
Alagiakrishnan K, Halverson T, Olivares DVF, Sadowski CA.   +3 more
europepmc   +1 more source

Clinician and patient factors associated with long‐term glucocorticoid use in people with rheumatoid arthritis on advanced therapies

Arthritis Care &Research, Accepted Article.
Background Despite guideline recommendations, long‐term glucocorticoid (GC) use is common in rheumatoid arthritis (RA). We conducted a clinician survey nested within a large registry to identify patient and clinician factors associated with GC use. Methods Clinicians contributing patients to the CorEvitas Rheumatoid Arthritis registry were surveyed ...
Michael D. George, George Reed, Matthew D. Kearney, Peter F. Cronholm, Kevin Kane, Jeffrey R. Curtis, Dimitrios A. Pappas, Joel M. Kremer   +7 more
wiley   +1 more source

Artificial Intelligence in Cardiovascular Medicine: A Giant Step in Personalized Medicine? [PDF]

J Pers Med
Jankauskas SS, Varzideh F, Kansakar U, Santulli G.   +3 more
europepmc   +1 more source

Employment Trajectories of Patients with Systemic lupus erythematosus (SLE) and Factors Driving Transitions Between States

Arthritis Care &Research, Accepted Article.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Materials and Methods Using data from a single center, we analyzed employment transitions, adjusted mean ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source